James M Cleary (James Cleary)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 33

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor. Cancer immunology research 12 (9) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Petros D Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, James J Harding, Elizabeth C Dees, Rastislav Bahleda, Nilofer S Azad, Asha Karippot, Razelle Kurzrock, Josep Tabernero, Juha Kononen, Matthew Chau Hsien Ng, Rutika Mehta, Nataliya V Uboha, Frédéric Bigot, Valentina Boni, Samantha E Bowyer, Valeriy Breder, Andres Cervantes, Nancy Chan, James M Cleary, Mallika Dhawan, Rikke Helene Løvendahl Eefsen, James Ewing, Donna M Graham, Tormod Kyrre Guren, Jin Won Kim, Krassimir Koynov, Do Youn Oh, Rebecca A Redman, Chia-Jui Yen, David B Spetzler, Marie-Claude Roubaudi-Fraschini, Valérie Nicolas, Rafik Ait-Sarkouh, Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T Flaherty
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan, Matthew J Oberley, Alex P Farrell, Rishi Surana, Brandon M Huffman, Kimberley J Perez, James M Cleary, Alexander C Jordan, Andressa Dias Costa, Hannah L Williams, Srivatsan Raghavan, Benjamin A Weinberg, Michael J Pishvaian, Rachna T Shroff, Sanjay Goel, Stephanie K Dougan, Jonathan Andrew Nowak, David B Spetzler, George W Sledge, Brian M Wolpin, Andrew J Aguirre
Clinical and genomic features of classical and basal transcriptional subtypes in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S Kapner, Bose S Kochupurakkal, David B Martignetti, Golbahar Sadatrezaei, Thomas A Abrams, Leah H Biller, Marios Giannakis, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Harshabad Singh, Douglas A Rubinson, Benjamin L Schlechter, Elizabeth Andrews, Alison M Hannigan, Stanley Dunwell, Zoe Getchell, Srivatsan Raghavan, Brian M Wolpin, Caroline Fortier, Alan D' Andrea, Andrew J Aguirre, Geoffrey I Shapiro, James M Cleary
A Phase 1 Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-Dose Gemcitabine in Metastatic Pancreatic Adenocarcinoma Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Harshabad Singh, Samuel J Klempner, Nelya Melnitchouk, Deepak P Chander, Ovidiu George Negrea, Anuj K Patel, Benjamin L Schlechter, Douglas A Rubinson, Brandon M Huffman, Chetan Nambiar, Joshua Remland, Elizabeth Andrews, Megan E Leahy, Lauren K Brais, Peter C Enzinger, Harvey J Mamon, Marios Giannakis, Jeffrey A Meyerhardt, Kimmie Ng, Kimberley J Perez, Andrew J Aguirre, Jeffrey W Clark, James M Cleary, Brian M Wolpin
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer. JCO precision oncology 7 (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Harshabad Singh, Rachel B Keller, Kevin S Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan, Elizabeth F Cohen, Michael Yevgeniy Tolstorukov, Elizabeth Andrews, Lauren K Brais, Annacarolina F L Da Silva, Kimberley J Perez, Douglas A Rubinson, Rishi Surana, Marios Giannakis, Kimmie Ng, Thomas E Clancy, Matthew B Yurgelun, Benjamin L Schlechter, Jeffrey W Clark, Geoffrey I Shapiro, Michael H Rosenthal, Jason L Hornick, Valentina Nardi, Yvonne Y Li, Hersh V Gupta, Andrew D Cherniak, Matthew L Meyerson, James M Cleary, Jonathan Andrew Nowak, Brian M Wolpin, Andrew J Aguirre
Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla, Jinming Zhang, Juha P Väyrynen, Mai Chan Lau, Hannah L Williams, Chen Yuan, Vicente Morales-Oyarvide, Dalia Elganainy, Harshabad Singh, James M Cleary, Kimberley J Perez, Kimmie Ng, William A Freed-Pastor, Joseph D Mancias, Stephanie K Dougan, Jiping Wang, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Lauren K Brais, Emma R Hill, Thomas E Clancy, David C Linehan, Daniel T Chang, Aram F Hezel, Albert C Koong, Andrew J Aguirre, Brian M Wolpin, Jonathan Andrew Nowak
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
James M Cleary, Betty Rouaisnel, Antoine Daina, Srivatsan Raghavan, Lauren A Roller, Brandon M Huffman, Harshabad Singh, Patrick Y Wen, Nabeel Bardeesy, Vincent Zoete, Brian M Wolpin, Julie-Aurore Losman
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma. NPJ precision oncology 6 (1) (2022)
Margherita Ambrosini, Marzia Del Re, Francesco Pantano, Andrew E Hendifar, Alexander E Drilon, Guilherme Harada, Anne Hansen Ree, Samuel J Klempner, Gunhild Mari Mælandsmo, Norman John Carr, Hege G Russnes, James M Cleary, Harshabad Singh, Elisa Sottotetti, Antonia Martinetti, Giovanni Randon, Andrea Sartore-Bianchi, Iolanda Capone, Massimo Milione, Maria Di Bartolomeo, Filippo Pietrantonio
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series. JCO precision oncology 6 (2022)
Hannah L Williams, Andressa Dias Costa, Jinming Zhang, Srivatsan Raghavan, Peter S Winter, Kevin S Kapner, Scott P Ginebaugh, Sara A Väyrynen, Juha P Väyrynen, Chen Yuan, Andrew W Navia, Junning Wang, Annan Yang, Timothy L Bosse, Radha L Kalekar, Kristen E Lowder, Mai Chan Lau, Dalia Elganainy, Vicente Morales-Oyarvide, Douglas A Rubinson, Harshabad Singh, Kimberley J Perez, James M Cleary, Thomas E Clancy, Jiping Wang, Joseph D Mancias, Lauren K Brais, Emma R Hill, Margaret M Kozak, David C Linehan, Richard F Dunne, Daniel T Chang, Albert C Koong, Aram F Hezel, William C Hahn, Alex K Shalek, Andrew J Aguirre, Jonathan Andrew Nowak, Brian M Wolpin
Spatially-resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intra-tumoral heterogeneity. Cancer research (2022)
James M Cleary, Emiliano Calvo, Victor Moreno, Dejan Juric, Geoffrey I Shapiro, Carol Ann Vanderwal, Beibei Hu, Maryella Gifford, David Barch, Lisa Roberts-Rapp, Peter J Ansell, Hao Xiong, Christopher Ocampo, Anthony W Tolcher
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR. Investigational new drugs 38 (5) (2020)
James M Cleary, Nora K Horick, Nadine Jackson McCleary, Thomas A Abrams, Matthew B Yurgelun, Christopher G Azzoli, Douglas A Rubinson, Gabriel A Brooks, Jennifer A Chan, Lawrence S Blaszkowsky, Jeffrey W Clark, Lipika Goyal, Jeffrey A Meyerhardt, Kimmie Ng, Deborah Schrag, Diane M F Savarese, Christopher Graham, Bridget Fitzpatrick, Kathryn A Gibb, Yves Boucher, Dan G Duda, Rakesh K Jain, Charles S Fuchs, Peter C Enzinger
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial. Cancer 125 (13) (2019)